PMID- 20536548 OWN - NLM STAT- MEDLINE DCOM- 20100902 LR - 20220409 IS - 1601-5223 (Electronic) IS - 0018-0661 (Linking) VI - 147 IP - 2 DP - 2010 Apr TI - Is there a genetic variation association in the IL-10 and TNF alpha promoter gene with gestational diabetes mellitus? PG - 94-102 LID - 10.1111/j.1601-5223.2009.02134.x [doi] AB - Gestational diabetes mellitus (GDM), defined as carbohydrate intolerance diagnosed for the first time during pregnancy, affects both maternal and fetal health. Possession of a specific genetic polymorphism can be a predisposing factor for susceptibility to some diseases. The aim of this study was to investigate the association between single nucleotide polymorphisms (SNP) in the promoter gene of interleukin-10 (IL-10) as well as tumor necrosis factor-alpha (TNF alpha) with the development of GDM. Two hundred and twelve consecutive series of eligible normal pregnant women (controls) and gestational diabetes mellitus women were selected based on the study's inclusion and exclusion criteria. DNA was extracted from blood and genotyped for IL-10 at three positions and TNF alpha for gene polymorphism using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. Plasma levels of IL-10 and TNF alpha at different gestational periods as well as postpartum were quantified using enzyme linked immunosorbent assay (ELISA). The results of the study showed that the difference in the frequency of SNP at position -597 in the promoter of the human IL-10 gene between the control and GDM groups was statistically significant (p < 0.05). In contrast, there was no significant difference in the frequency of SNP at the other two sites in the promoter region of the human IL-10 gene (-824 and -1082) as well as position -308 in the promoter of the human TNF-alpha (p > 0.05). In addition, there was no significant difference between the two groups in terms of plasma levels of IL-10 as well as TNF alpha in different stages of pregnancy. SNP at position -597 was significantly associated with the development of GDM and shows potential for use as a predictive marker for GDM. FAU - Montazeri, Shabnam AU - Montazeri S AD - Department of Obstetrics and Gynecology, Faculty of Medicine and Health, International Medical University (IMU), Bukit Jalil, Kuala Lumpur, Malaysia. shabnam_montazeri@yahoo.com FAU - Nalliah, Sivalingam AU - Nalliah S FAU - Radhakrishnan, Ammu Kutty AU - Radhakrishnan AK LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Hereditas JT - Hereditas JID - 0374654 RN - 0 (Tumor Necrosis Factor-alpha) RN - 130068-27-8 (Interleukin-10) SB - IM MH - Adult MH - Case-Control Studies MH - Diabetes, Gestational/*genetics MH - Female MH - *Genetic Variation MH - Humans MH - Interleukin-10/*genetics MH - Middle Aged MH - Pregnancy MH - *Promoter Regions, Genetic MH - Tumor Necrosis Factor-alpha/*genetics EDAT- 2010/06/12 06:00 MHDA- 2010/09/03 06:00 CRDT- 2010/06/12 06:00 PHST- 2010/06/12 06:00 [entrez] PHST- 2010/06/12 06:00 [pubmed] PHST- 2010/09/03 06:00 [medline] AID - HRD2134 [pii] AID - 10.1111/j.1601-5223.2009.02134.x [doi] PST - ppublish SO - Hereditas. 2010 Apr;147(2):94-102. doi: 10.1111/j.1601-5223.2009.02134.x.